中医药靶向长链非编码RNA治疗动脉粥样硬化的创新策略
该综述探讨长链非编码RNA(lncRNA)在动脉粥样硬化(AS)发病中的作用,以及中医药通过靶向调控lncRNA防治AS的最新进展。文中总结了16种中药单体与6种中药复方,并分析了中医药的毒理学问题,为AS治疗提供新靶点并拓展中医药在心血管疾病中的应用。
要点
- lncRNA参与内皮功能障碍、血管平滑肌细胞异常增殖、泡沫细胞形成等AS关键环节
- 中药单体与复方可靶向调控lncRNA,为AS防治提供潜在新靶点
- 应用中医药靶向lncRNA时需关注其毒理学安全性
核心结论
- 中医药单体、提取物及复方通过靶向调控lncRNA在AS防治中具有重要潜力和意义。
研究设计与样本
- 综述检索PubMed、Web of Science、CNKI、Elsevier、ScienceDirect、SpringerLink、Google Scholar等数据库。
主要发现
- lncRNA通过内皮细胞功能障碍、血管平滑肌细胞异常增殖、巨噬细胞胆固醇堆积、泡沫细胞形成、炎症反应及脂代谢失衡等机制诱导AS。
- 综述总结了16种中药单体和6种中药复方,并分析了中医药毒理学方面。
临床怎么用
- 可将lncRNA作为AS中医药干预的潜在靶点,关注中药单体、提取物及复方的调控作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherosclerosis (AS) is a major contributor to cardiovascular diseases, characterized by high morbidity and mortality rates. Long non-coding RNAs (LncRNAs), as members of non-protein coding RNAs, play a crucial role in various biological processes that maintain homeostasis and influence disease progression. Research indicates that lncRNAs are involved in the pathogenesis of AS. PURPOSE: In this study, we aim to explore the role of lncRNAs in the pathogenesis of AS and the latest progress in the prevention and treatment of AS by targeted regulation of lncRNAs by traditional Chinese medicine (TCM), in order to provide more new beneficial targets for the treatment of AS and expand the application of TCM in the treatment of cardiovascular diseases. METHOD: The literature was retrieved, analyzed, and collected using PubMed, Web of Science, Sci-Hub, CNKI, Elsevier, ScienceDirect, SpringerLink, and Google Scholar. Search terms include "atherosclerosis", "traditional Chinese medicine", "natural products", "active ingredient", "lncRNAs", "herbal medicine", "cardiovascular diseases", "pharmacology", "toxicology", "clinical trials", etc., and several combinations of these keywords. RESULTS: This study examines the primary mechanisms through which lncRNAs induce AS, such as dysfunction in endothelial cells, abnormal proliferation of vascular smooth muscle cells, cholesterol buildup in macrophages, formation of foam cells, inflammatory responses, and imbalances in lipid metabolism. Additionally, it summarizes 16 herbal monomers and 6 Chinese herbal compounds, along with an analysis of the toxicological aspects of TCM. CONCLUSION: The study explores the existing approaches for modulating lncRNAs and emphasizes the significance and potential of herbal monomers, extracts, and formulations in this context.
引用
- Chen X, Ding W, Liu Y, et al. Innovative approaches in atherosclerosis treatment: Harnessing traditional Chinese medicine to target long non-coding RNAs. Phytomedicine. 2025. PMID: 39938175. doi:10.1016/j.phymed.2025.156488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。